Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q1 EPS of ($0.68), $0.05 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $6.5 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.